Total Payments
$2,014
2024 Payments
$53.77
Companies
21
Transactions
99
Medicare Patients
5,271
Medicare Billing
$425,539
Payment Breakdown by Category
Food & Beverage$1,896 (94.2%)
Education$117.65 (5.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,896 | 97 | 94.2% |
| Education | $117.65 | 2 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $397.15 | 16 | $0 (2022) |
| Stryker Corporation | $232.61 | 5 | $0 (2022) |
| Optinose US, Inc. | $229.98 | 14 | $0 (2024) |
| Acclarent, Inc | $208.21 | 7 | $0 (2022) |
| Shire North American Group Inc | $109.56 | 5 | $0 (2018) |
| GlaxoSmithKline, LLC. | $103.42 | 7 | $0 (2022) |
| ABBVIE INC. | $100.33 | 7 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $92.56 | 7 | $0 (2022) |
| Intersect ENT, Inc. | $83.35 | 5 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $82.62 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.77 | 2 | Optinose US, Inc. ($53.77) |
| 2023 | $37.09 | 2 | Optinose US, Inc. ($37.09) |
| 2022 | $852.32 | 36 | Regeneron Healthcare Solutions, Inc. ($300.43) |
| 2021 | $273.71 | 15 | Regeneron Healthcare Solutions, Inc. ($66.01) |
| 2020 | $229.67 | 14 | Stryker Corporation ($46.69) |
| 2019 | $91.99 | 5 | Acclarent, Inc ($32.40) |
| 2018 | $266.83 | 15 | Acclarent, Inc ($92.22) |
| 2017 | $208.34 | 10 | Shire North American Group Inc ($70.40) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/06/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/31/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/01/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/22/2022 | Aerin Medical Inc. | — | Food and Beverage | In-kind items and services | $27.51 | General |
| 12/13/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/01/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/13/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/06/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/04/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2022 | Acclarent, Inc | ACCLARENT Balloon Inflation Device (Device) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Rhinology Laryngology | ||||||
| 09/20/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $24.77 | General |
| Category: Allergy/Immunology | ||||||
| 09/15/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/30/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.88 | General |
| Category: Allergy/Immunology | ||||||
| 08/18/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/02/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $80.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/26/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/11/2022 | Aerin Medical Inc. | — | Food and Beverage | In-kind items and services | $23.91 | General |
| 07/05/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2022 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,183 | 1,503 | $330,072 | $88,242 |
| 2022 | 9 | 1,509 | 2,083 | $283,738 | $121,328 |
| 2021 | 9 | 1,277 | 1,794 | $244,077 | $108,709 |
| 2020 | 12 | 1,302 | 1,817 | $259,873 | $107,260 |
Total Patients
5,271
Total Services
7,197
Medicare Billing
$425,539
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 449 | 588 | $120,370 | $34,220 | 28.4% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 104 | 133 | $47,234 | $12,254 | 25.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 286 | 416 | $45,922 | $12,114 | 26.4% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 44 | 50 | $21,000 | $6,830 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 72 | $21,855 | $6,262 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $20,280 | $5,039 | 24.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 117 | 129 | $21,981 | $5,005 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $16,252 | $3,491 | 21.5% |
| 69436 | Incision of eardrum with placement of eardrum tube under general anesthesia | Facility | 2023 | 20 | 21 | $15,179 | $3,029 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 515 | 778 | $104,252 | $48,671 | 46.7% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 357 | 564 | $45,120 | $16,612 | 36.8% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 123 | 175 | $36,750 | $14,901 | 40.5% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 63 | 71 | $23,714 | $9,220 | 38.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 203 | 233 | $19,106 | $8,562 | 44.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 97 | 97 | $16,199 | $7,151 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 85 | $16,150 | $6,575 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $16,191 | $6,544 | 40.4% |
| 30903 | Complex control of nose bleed | Office | 2022 | 13 | 17 | $6,256 | $3,091 | 49.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 400 | 577 | $75,844 | $36,597 | 48.3% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 113 | 187 | $39,270 | $16,307 | 41.5% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 304 | 482 | $38,560 | $14,455 | 37.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 201 | 272 | $21,644 | $10,443 | 48.2% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 65 | 75 | $25,050 | $10,153 | 40.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 73 | 73 | $12,191 | $5,617 | 46.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $11,308 | $5,332 | 47.2% |
About Dr. Joseph Puzzi, MD
Dr. Joseph Puzzi, MD is a Otolaryngology healthcare provider based in Pottsville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205829496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Puzzi, MD has received a total of $2,014 in payments from pharmaceutical and medical device companies, with $53.77 received in 2024. These payments were reported across 99 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,896).
As a Medicare-enrolled provider, Puzzi has provided services to 5,271 Medicare beneficiaries, totaling 7,197 services with total Medicare billing of $425,539. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Pottsville, PA
- Active Since 08/24/2005
- Last Updated 01/16/2023
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1205829496
Products in Payments
- DUPIXENT (Biological) $434.32
- Xhance (Drug) $229.98
- HYDROSET (Device) $153.13
- NATPARA (Drug) $109.56
- NUCALA (Biological) $103.42
- Dexilant (Drug) $100.29
- ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM (Device) $93.26
- XOLAIR (Biological) $82.02
- PROPEL (Device) $58.00
- ACCLARENT SE Inflation Device (Device) $57.82
- Synthroid (Drug) $56.76
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $46.69
- SYNTHROID (Drug) $43.57
- ImmunoCAP (Device) $42.65
- Tirosint (Drug) $34.69
- Otiprio (Drug) $31.88
- ACCLARENT ENT ULTIRRA/NAVWIRE 3-GUIDE Bundle (Device) $31.36
- ACCLARENT Balloon Inflation Device (Device) $25.77
- SINUVA (Drug) $25.35
- TULA System (Device) $25.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.